EUS-Guided Intragastric Injection of Botulinum Toxin A in the Preoperative Treatment of Super-Obese Patients: a Randomized Clinical Trial

Botulinum toxin injection vs topical nitrates for chronic anal fissure: an updated systematic review and meta-analysis of randomized controlled trials

(2018) S. M. Sahebally et al.   Colorectal Disease

Tu1899 THE EFFECTIVENESS OF ENDOSCOPIC GASTROPLASTY FOR OBESITY TREATMENT ACCORDING TO FDA THRESHOLDS: SYSTEMATIC REVIEW AND META-ANALYSIS BASED ON RANDOMIZED CONTROLLED TRIALS

(2018) Antonio C. Madruga Neto et al.   GASTROINTESTINAL ENDOSCOPY

Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases

(2018) Manoel Galvao Neto et al.   Surgery for Obesity and Related Diseases

Duration of effectiveness of Botulinum toxin type A in excessive gingival display: a systematic review and meta-analysis

(2018) Taísa Figueiredo Chagas et al.   Brazilian Oral Research

Progress and challenges in anti-obesity pharmacotherapy

(2018) Daniel H Bessesen et al.   Lancet Diabetes & Endocrinology

Endoscopic dual therapy for giant peptic ulcer hemorrhage

(2018) Igor Ribeiro et al.   ENDOSCOPY

Botulinum toxin: State of the art

(2017) Joseph Jankovic   MOVEMENT DISORDERS

Obesity Treatment with Botulinum Toxin-A Is Not Effective: a Systematic Review and Meta-Analysis

(2017) Fabio Bustamante et al.   OBESITY SURGERY

The Role of Endoscopic Intra-Gastric Botulinum Toxin-A for Obesity Treatment

(2017) Hadya Elshakh et al.   OBESITY SURGERY

Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology

(2017) Marco Pirazzini et al.   PHARMACOLOGICAL REVIEWS

Inhibitory neurotransmission regulates vagal efferent activity and gastric motility

(2016) Caitlin A McMenamin et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Gastric Artery Embolization Trial for the Lessening of Appetite Nonsurgically (GET LEAN): Six-Month Preliminary Data

(2016) Mubin I. Syed et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Botulinum Toxin: Preparations for Clinical Use, Immunogenicity, Side Effects, and Safety Profile

(2016) Farzin Pedouim et al.   SEMINARS IN NEUROLOGY

Perioperative Outcomes of Proximal and Distal Gastric Bypass in Patients with BMI Ranged 50–60 kg/m2—A Double-Blind, Randomized Controlled Trial

(2015) Marius Svanevik et al.   OBESITY SURGERY

Botulinum toxins: Mechanisms of action, antinociception and clinical applications

(2013) Anthony Wheeler et al.   TOXICOLOGY

Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders

(2013) Mark Hallett et al.   TOXICON

Gastric Antral Injections of Botulinum Toxin Delay Gastric Emptying but Do Not Reduce Body Weight

(2012) Mark Topazian et al.   Clinical Gastroenterology and Hepatology

Benefit-risk paradigm for clinical trial design of obesity devices: FDA proposal

(2012) Herbert Lerner et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Metabolic Improvements in Obese Type 2 Diabetes Subjects Implanted for 1 Year with an Endoscopically Deployed Duodenal–Jejunal Bypass Liner

(2011) Eduardo G.H. de Moura et al.   Diabetes Technology & Therapeutics

Analysis of pacemaker activity in the human stomach

(2011) Poong-Lyul Rhee et al.   JOURNAL OF PHYSIOLOGY-LONDON

Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients

(2009) Rosario Forlano et al.   GASTROINTESTINAL ENDOSCOPY

Effects of intramural administration of Botulinum Toxin A on gastric emptying and eating capacity in obese patients

(2008) D. Foschi et al.   DIGESTIVE AND LIVER DISEASE